← Back
$ETON All transactions

Eton Pharmaceuticals, Inc.

F

$ Value

$77K

Shares

5,015

Price

$15

Filed

Jan 14

Insider

Name

BRYNJELSEN SEAN

Title

President & CEO

CIK

0001669976

Roles

Director Officer 10% Owner

Transaction Details

Transaction Date

2026-01-01

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,889,266

Footnotes

Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units. | The shares were sold in multiple trades at prices ranging from $15.39 to $15.42. The price reported above reflects the weighted average sales price. | The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. | The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on January 12, 2030. | Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock. | The restricted stock units vest in four equal annual installments beginning January 12, 2027, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.

Filing Info

Accession No.

0001437749-26-001290

Form Type

4

Issuer CIK

0001710340

BRYNJELSEN SEAN's History

Date Ticker Type Value
2026-01-12 ETON A $0
2026-01-12 ETON A $0
2026-01-01 ETON F $77K
2025-12-12 ETON F $113K
2025-06-05 ETON $1.2M
2025-06-04 ETON $1.2M
2025-06-03 ETON $1.1M
2025-06-03 ETON $159K
2025-06-03 ETON $8K

Other Insiders at ETON (90d)

Insider Bought Sold Last
RIEDEL NORBERT G 2026-04-21